Scott v. Takeda Pharmaceuticals U.S.A. Inc. et al
Garrison Scott |
Takeda Pharmaceuticals America, Inc and Takeda Pharmaceuticals U.S.A. Inc. |
1:2020cv01062 |
February 13, 2020 |
US District Court for the Northern District of Illinois |
Matthew F Kennelly |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. ยง 1332 |
Both |
Docket Report
This docket was last retrieved on March 30, 2020. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 12 ORDER Seconded Amended General Order 20-0012 IN RE: CORONAVIRUS COVID-19 PUBLIC EMERGENCY Signed by the Chief Judge Rebecca R. Pallmeyer on March 30, 2020. All open cases are impacted by this Second Amended General Order. Amended General Order 20-0012, entered on March 17, 2020, and General Order 20-0014, entered on March 20, 2020, are vacated and superseded by this Second Amended General. See attached Order for guidance.Signed by the Honorable Rebecca R. Pallmeyer on 3/30/2020: Mailed notice. (docket8, ) |
Filing 11 ATTORNEY Appearance for Defendants Takeda Pharmaceuticals America, Inc, Takeda Pharmaceuticals U.S.A. Inc. by Brittany Lynne Weiss (Weiss, Brittany) |
Filing 10 ATTORNEY Appearance for Defendants Takeda Pharmaceuticals America, Inc, Takeda Pharmaceuticals U.S.A. Inc. by James R M Hemmings (Hemmings, James) |
Filing 9 ATTORNEY Appearance for Defendants Takeda Pharmaceuticals America, Inc, Takeda Pharmaceuticals U.S.A. Inc. by Sherry Ann Knutson (Knutson, Sherry) |
Filing 8 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Takeda Pharmaceuticals America, Inc, Takeda Pharmaceuticals U.S.A. Inc. (Glinka Przybysz, Andrea) |
Filing 7 ANSWER to Complaint with Jury Demand and Separate or Affirmative Defenses by Takeda Pharmaceuticals America, Inc, Takeda Pharmaceuticals U.S.A. Inc.(Glinka Przybysz, Andrea) |
Filing 6 ATTORNEY Appearance for Defendants Takeda Pharmaceuticals America, Inc, Takeda Pharmaceuticals U.S.A. Inc. by Andrea Marie Glinka Przybysz (Glinka Przybysz, Andrea) |
Filing 5 SUMMONS Returned Executed by Garrison Scott as to Takeda Pharmaceuticals U.S.A. Inc. on 3/5/2020, answer due 3/26/2020. (Durant, Christine) |
Filing 4 SUMMONS Returned Executed by Garrison Scott as to Takeda Pharmaceuticals America, Inc on 3/5/2020, answer due 3/26/2020. (Durant, Christine) |
Filing 3 ORDER Amended General Order 20-0012 IN RE: CORONAVIRUS COVID-19 PUBLIC EMERGENCY Signed by the Chief Judge Rebecca R. Pallmeyer on March 16, 2020. All open cases are impacted by this Amended General Order. See attached Order for guidance.Signed by the Honorable Rebecca R. Pallmeyer on 3/16/2020: Mailed notice. (ecw, ) |
Filing 2 EXECUTIVE COMMITTEE ORDER:It appearing that, for reasons of judicial efficiency, coordinated pretrial proceedings in the cases listed below should be presided over by a single district judge as provided for by IOP13(e) and that a single magistrate judge should be designated for these cases; and It further appearing that the Hon. Matthew F. Kennelly, has agreed to preside over these proceedings;and It further appearing that Magistrate Judge Young B. Kim has agreed to be the designated magistrate judge in these proceedings; therefore It is hereby ordered that Judge Kennelly shall preside over pretrial proceedings, including case management and discovery supervision, in the cases listed below; and It is further ordered that Magistrate Judge Kim shall be the designated magistrate judge; and It is further ordered that these cases shall remain pending on the calendars of the judges to whom they are currently assigned, and that an order be entered in each case by Judge Kennelly at such time as coordinated pretrial proceedings have concluded; and It is further ordered that the Clerk of Court shall open a new civil case (20 CV 623, In Re: Uloric Products Liability Coordinated Pretrial Proceedings) under which all future filings related to these coordinated pretrial proceedings shall be filed; and It is further ordered that the Clerk of Court shall link the individual cases listed below to 20 CV 623, In Re: Uloric Products Liability Coordinated Pretrial Proceedings. Signed by Executive Committee on 3/12/20.(las, ) |
SUMMONS Issued as to Defendants Takeda Pharmaceuticals America, Inc, and Takeda Pharmaceuticals U.S.A. Inc. (acm, ) |
Filing 1 COMPLAINT for Plaintiff, Garrison Scott filed by Garrison Scott; Jury Demand. Filing fee $ 400, receipt number 0752-16723706. (Attachments: #1 Civil Cover Sheet Civil Cover Sheet)(Flowers, Peter) |
CASE ASSIGNED to the Honorable Matthew F. Kennelly. Designated as Magistrate Judge the Honorable Sidney I. Schenkier. Case assignment: Random assignment. (jg, ) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Illinois Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.